Dechra Brand Guidelines

Contents.

Vetoryl is the only veterinary licensed pharmaceutical treatment for pituitary-dependent hyperadrenocorticism (PDH) and adrenal-dependent canine hyperadrenocorticism (ADH).

04 Welcome to the brand 05 Our key brand insight

07 Logo sizes & colours 08 Clear zone 09 Logo grid & positioning line 10 Vetoryl & Dechra logo

Key benefits and features:

• Available in 10 mg, 30 mg, 60 mg, and 120 mg, providing dosing options for dogs of all sizes. • Improvements may be seen within several weeks. • Contains the active ingredient trilostane, which blocks the excessive production of cortisol. • Daily administration may greatly reduce the clinical signs associated with Cushing’s syndrome. • Reducing or eliminating clinical signs of Cushing’s syndrome enhances the quality of life for both dog and owner. • Managing Cushing’s syndrome with Vetoryl capsules can also contribute to the revenue of the clinic.

12 Colour palette

14 Typeface

16 Tone of voice

18 Photography

24 Application style

30 Brand checklist

This document is for internal use only.